Insider Trading activities of Allogene Therapeutics, Inc. (ALLO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allogene Therapeutics, Inc. (ALLO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allogene Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Allogene Therapeutics, Inc. since 2005. The reporting company's ticker symbol is ALLO. The reporting company's CIK number is 1737287.
The total value of stock buying since 2005 is $15,310,008.
The total value of stock sales since 2005 is $56,373,021.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Allogene Therapeutics, Inc. (ALLO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 0 $0 1,918,755 $56,373,021 0 $0
2018-10 850,556 $15,310,008 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Allogene Therapeutics, Inc. insiders (ALLO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-14 Coulter James G Sale 1,918,755 29.38 56,373,021
2018-10-15 Witte Owen N. (Director) Buy 15,000 18.00 270,000
2018-10-15 Chang David D (President and CEO) Buy 40,000 18.00 720,000
2018-10-15 Humer Franz B (Director) Buy 30,000 18.00 540,000
2018-10-15 Belldegrun Arie (Director) Buy 35,000 18.00 630,000
2018-10-15 Coulter James G Buy 675,000 18.00 12,150,000
2018-10-15 Pfizer Inc (10% Owner) Buy 55,556 18.00 1,000,008

Insider trading activities including stock purchases, stock sales, and option exercises of ALLO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allogene Therapeutics, Inc. (symbol ALLO, CIK number 1737287) see the Securities and Exchange Commission (SEC) website.